Proveca is a pharmaceutical company which develops medicines designed specifically for children
Initial investment
2012
Status
Current holding
Why we invested
Most medicines are made for adults and used off-label in children, causing significant patient inconvenience and potential safety risks.
Proveca exists to develop and bring to market medicines specifically formulated with the child in mind
Development
Proveca's strategy is to develop existing drugs for new markets that benefit from exclusivity, thereby generating significant value.
Since we led the pre-seed investment, the company has brought 3 medicines to market, has established four offices across Europe and is generating sales in 22 countries across two continents.
Key Stats
60+
Employees
4
Office locations
3
Medicines in the market
Explore Our Solutions
Albion manages £1bn in AUM, invested across a platform of strategies, from pre-seed to growth stage
Questions?
Get in touch.
Further Case Studies
PSE is a process modelling software providing model-based innovation services.
Read more
Phasecraft is a quantum algorithm company led by leading academics from UCL and the University of Bristol
Read more
Oviva is Europe's leading digital health company focused on obesity and weight loss.
Read more
Grapeshot, a contextual intelligence platform that empowers brands to deliver relevance to every customer experience
Read more
